Zymergi LogoCart

483 Document: Reveragen Biopharma Inc., Mar 6, 2023

FDANews 483 Reveragen Biopharma Inc. Mar 6 2023 top
David L. Chon FDA Investigator Glenn B. Mannheim FDA Investigator

On Mar 06, 2023, the FDA inspected Reveragen Biopharma Inc.'s Rockville site. Explore the inspectional observations.